Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity

Behavioural Brain Research

Volumn 225, Issue 1, 2011, Pages 373-376

  Russo, Emilio ^a   Citraro, Rita ^a   Scicchitano, Francesca ^a   Urzino, Agostina ^a   Marra, Rosario ^b   Rispoli, Vincenzo ^a   De Sarro, Giovambattista ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

Absence; Anticonvulsant; Epileptogenesis; Forced swimming test; SWD

Indexed keywords

VIGABATRIN;

ABSENCE; ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CHRONIC DRUG ADMINISTRATION; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG RESPONSE; EARLY INTERVENTION; EPILEPSY; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SUBCHRONIC DRUG ADMINISTRATION; WISTAR ALBINO GLAXO RAT; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; IMMOBILITY RESPONSE, TONIC; MALE; RANDOM ALLOCATION; RATS; RATS, MUTANT STRAINS; RATS, WISTAR; SWIMMING; VIGABATRIN;

EID: 80052405638     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.07.030     Document Type: Article

References (31)

1. Morimoto K., Fahnestock M., Racine R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 2004, 73:1-60.
2. Kanner A.M. Depression and epilepsy. A bidirectional relation?. Epilepsia 2011, 52:21-27.
3. Jones N.C., Salzberg M.R., Kumar G., Couper A., Morris M.J., O'Brien T.J. Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation. Exp Neurol 2008, 209:254-260.
4. van Luijtelaar G. The prevention of behavioral consequences of idiopathic generalized epilepsy: evidence from rodent models. Neurosci Lett 2011, 497:177-184.
5. Russo E., Citraro R., Scicchitano F., De Fazio S., Di Paola E., Constanti A., et al. Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia 2010, 51:1560-1569.
6. Russo E., Citraro R., Scicchitano F., De Fazio S., Perrota I., Donato Di Paola E., et al. Effects of early long-term treatment with antiepileptic drugs, on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia 2011, 52:1341-1350.
7. Ghose S., Winter M.K., McCarson K.E., Tamminga C.A., Enna S.J. The GABAβ receptor as a target for antidepressant drug action. Br J Pharmacol 2011, 162:1-17.
8. Houser C.R., Esclapez M. Vulnerability and plasticity of the GABA system in the pilocarpine model of spontaneous recurrent seizures. Epilepsy Res 1996, 26:207-218.
9. Shirasaka Y., Wasterlain C.G. Chronic epileptogenicity following focal status epilepticus. Brain Res 1994, 655:33-44.
10. Brooks-Kayal A.R., Shumate M.D., Jin H.T., Rikhter Y., Coulter D.A. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 1998, 4:1166-1172.
11. Rice A., Rafiq A., Shapiro S.M., Jakoi E.R., Coulter D.A., DeLorenzo R.J. Long-lasting reduction of inhibitory function and gamma-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy. Proc Natl Acad Sci USA 1996, 93:9665-9669.
12. Sperk G., Schwarzer C., Tsunashima K., Kandlhofer S. Expression of GABA(A) receptor subunits in the hippocampus of the rat after kainic acid-induced seizures. Epilepsy Res 1998, 32:129-139.
13. Verhoeff N.P., Petroff O.A., Hyder F., Zoghbi S.S., Fujita M., Rajeevan N., et al. Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS. Epilepsia 1999, 40:1433-1438.
14. Loscher W., Jackel R., Muller F. Anticonvulsant and procovulsant effects of inhibitors of GABA degradation in the amygdala-kindling model. Eur J Pharmacol 1989, 163:1-14.
15. Wu Y., Wang W., Richerson G.B. Vigabatrin induces tonic inhibition via GABA transporter reversal without increasing vesicular GABA release. J Neurophysiol 2003, 89:2021-2034.
16. Willmore L.J., Abelson M.B., Ben-Menachem E., Pellock J.M., Shields W.D. Vigabatrin: 2008 update. Epilepsia 2009, 50:163-173.
17. Holland K.D., McKeon A.C., Canney D.J., Covey D.F., Ferrendelli J.A. Relative anticonvulsant effects of GABAmimetic and GABA modulatory agents. Epilepsia 1992, 33:981-986.
18. Liu Z., Seiler N., Marescaux C., Depaulis A., Vergnes M. Potentiation of gamma-vinyl GABA (vigabatrin) effects by glycine. Eur J Pharmacol 1990, 182:109-115.
19. Shin C., Rigsbee L.C., McNamara J.O. Anti-seizure and antiepileptogenic effect of (-vinyl(-aminobutyric acid in amygdaloid kindling. Brain Res 1986, 398:370-374.
20. Panayiotopoulos C.P., Agathonikou A., Sharoqi I.A., Parker A.P. Vigabatrin aggravates absences and absence status. Neurology 1997, 49:1467.
21. Croarkin P.E., Levinson A.J., Daskalakis Z.J. Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci Biobehav Rev 2011, 35:818-825.
22. Mula M., Sander J.W. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf 2007, 30:555-567.
23. Semba J., Kuroda Y., Takahashi R. Potential antidepressant properties of subchronic GABA transaminase inhibitors in the forced swimming test in mice. Neuropsychobiology 1989, 21:152-156.
24. Bouwman B.M., Suffczynski P., Midzyanovskaya I.S., Maris E., van den Broek P.L., van Rijn C.M. The effects of vigabatrin on spike and wave discharges in WAG/Rij rats. Epilepsy Res 2007, 76:34-40.
25. Russo E., Constanti A., Ferreri G., Citraro R., De Sarro G. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 2004, 46:865-878.
26. Sarkisova K., van Luijtelaar G. The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:854-876.
27. Sarkisova K.Y., Kuznetsova G.D., Kulikov M.A., van Luijtelaar G. Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms. Epilepsia 2010, 51:146-160.
28. Peeters B.W., Kerbusch J.M., Coenen A.M., Vossen J.M., van Luijtelaar E.L. Genetics of spike-wave discharges in the electroencephalogram (EEG) of the WAG/Rij inbred rat strain: a classical mendelian crossbreeding study. Behav Genet 1992, 22:361-368.
29. André V., Ferrandon A., Marescaux C., Nehlig A. Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res 2001, 47:99-117.
30. Jolkkonen J., Halonen T., Jolkkonen E., Nissinen J., Pitkänen A. Seizure-induced damage to the hippocampus is prevented by modulation of the GABAergic system. Neuroreport 1996, 7:2031-2035.
31. Vergnes M., Marescaux C., Micheletti G., Depaulis A., Rumbach L., Warter J.M. Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit-mal-like epilepsy. Neurosci Lett 1984, 44:91-94.